JP2542241B
NEW MATERIAL:A peptide (salt) expressed by formula l or a derivative at the functional group thereof. USE:A preventive and treating agent for senile dementia, cerebrovascular dementia, Alzheimer disease, Pick disease, Huntington chorea, Creutzfeldt.Jakob disease, Parkinson disease, cerebellospinal d...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | MAZAKI MITSUO MYAKE MASAHISA UEHARA MASAKI HIRATE KENJI NAKAJIMA YOSHIHARU ISOWA YOSHIKAZU SATO YOSHIAKI |
description | NEW MATERIAL:A peptide (salt) expressed by formula l or a derivative at the functional group thereof. USE:A preventive and treating agent for senile dementia, cerebrovascular dementia, Alzheimer disease, Pick disease, Huntington chorea, Creutzfeldt.Jakob disease, Parkinson disease, cerebellospinal degeneration, etc. PREPARATION:For example, a compound expressed by he formula H-Arg(Mbs)- OBzl (Mbs is p-methoxybenzenesufonyl; OBzl is benzyl ester) is reacted with a compound expressed by the formula Boc-Pro-Osu (Boc is tert-butoxycarbonyl; Osu is N-hyroxysuccinimide ester) in THF to provide a compound expressed by formula II. The alpha-amino-protecting group thereof is then removed and the resultant compound is successively reacted with compounds expressed by the formula Boc-Cys(MBzl)OH (MBzl is p-methoxybenzyl) and Z-Asn-OH (Z is benzyloxycarbonyl) to afford a protected peptide expressed by formula III. The protecting groups are then removed to provide the compound expressed by formula I. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2542241BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2542241BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2542241BB23</originalsourceid><addsrcrecordid>eNrjZODyCjAyNTEyMjF04mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8QgNTkbGxKgBACG-G1U</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>JP2542241B</title><source>esp@cenet</source><creator>MAZAKI MITSUO ; MYAKE MASAHISA ; UEHARA MASAKI ; HIRATE KENJI ; NAKAJIMA YOSHIHARU ; ISOWA YOSHIKAZU ; SATO YOSHIAKI</creator><creatorcontrib>MAZAKI MITSUO ; MYAKE MASAHISA ; UEHARA MASAKI ; HIRATE KENJI ; NAKAJIMA YOSHIHARU ; ISOWA YOSHIKAZU ; SATO YOSHIAKI</creatorcontrib><description>NEW MATERIAL:A peptide (salt) expressed by formula l or a derivative at the functional group thereof. USE:A preventive and treating agent for senile dementia, cerebrovascular dementia, Alzheimer disease, Pick disease, Huntington chorea, Creutzfeldt.Jakob disease, Parkinson disease, cerebellospinal degeneration, etc. PREPARATION:For example, a compound expressed by he formula H-Arg(Mbs)- OBzl (Mbs is p-methoxybenzenesufonyl; OBzl is benzyl ester) is reacted with a compound expressed by the formula Boc-Pro-Osu (Boc is tert-butoxycarbonyl; Osu is N-hyroxysuccinimide ester) in THF to provide a compound expressed by formula II. The alpha-amino-protecting group thereof is then removed and the resultant compound is successively reacted with compounds expressed by the formula Boc-Cys(MBzl)OH (MBzl is p-methoxybenzyl) and Z-Asn-OH (Z is benzyloxycarbonyl) to afford a protected peptide expressed by formula III. The protecting groups are then removed to provide the compound expressed by formula I.</description><edition>6</edition><language>eng</language><subject>CHEMISTRY ; CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION ORPROCESSING OF GOODS ; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC ; GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS ; TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE</subject><creationdate>1996</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19961009&DB=EPODOC&CC=JP&NR=2542241B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25544,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19961009&DB=EPODOC&CC=JP&NR=2542241B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MAZAKI MITSUO</creatorcontrib><creatorcontrib>MYAKE MASAHISA</creatorcontrib><creatorcontrib>UEHARA MASAKI</creatorcontrib><creatorcontrib>HIRATE KENJI</creatorcontrib><creatorcontrib>NAKAJIMA YOSHIHARU</creatorcontrib><creatorcontrib>ISOWA YOSHIKAZU</creatorcontrib><creatorcontrib>SATO YOSHIAKI</creatorcontrib><title>JP2542241B</title><description>NEW MATERIAL:A peptide (salt) expressed by formula l or a derivative at the functional group thereof. USE:A preventive and treating agent for senile dementia, cerebrovascular dementia, Alzheimer disease, Pick disease, Huntington chorea, Creutzfeldt.Jakob disease, Parkinson disease, cerebellospinal degeneration, etc. PREPARATION:For example, a compound expressed by he formula H-Arg(Mbs)- OBzl (Mbs is p-methoxybenzenesufonyl; OBzl is benzyl ester) is reacted with a compound expressed by the formula Boc-Pro-Osu (Boc is tert-butoxycarbonyl; Osu is N-hyroxysuccinimide ester) in THF to provide a compound expressed by formula II. The alpha-amino-protecting group thereof is then removed and the resultant compound is successively reacted with compounds expressed by the formula Boc-Cys(MBzl)OH (MBzl is p-methoxybenzyl) and Z-Asn-OH (Z is benzyloxycarbonyl) to afford a protected peptide expressed by formula III. The protecting groups are then removed to provide the compound expressed by formula I.</description><subject>CHEMISTRY</subject><subject>CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION ORPROCESSING OF GOODS</subject><subject>GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC</subject><subject>GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</subject><subject>TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1996</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZODyCjAyNTEyMjF04mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8QgNTkbGxKgBACG-G1U</recordid><startdate>19961009</startdate><enddate>19961009</enddate><creator>MAZAKI MITSUO</creator><creator>MYAKE MASAHISA</creator><creator>UEHARA MASAKI</creator><creator>HIRATE KENJI</creator><creator>NAKAJIMA YOSHIHARU</creator><creator>ISOWA YOSHIKAZU</creator><creator>SATO YOSHIAKI</creator><scope>EVB</scope></search><sort><creationdate>19961009</creationdate><title>JP2542241B</title><author>MAZAKI MITSUO ; MYAKE MASAHISA ; UEHARA MASAKI ; HIRATE KENJI ; NAKAJIMA YOSHIHARU ; ISOWA YOSHIKAZU ; SATO YOSHIAKI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2542241BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1996</creationdate><topic>CHEMISTRY</topic><topic>CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION ORPROCESSING OF GOODS</topic><topic>GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC</topic><topic>GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS</topic><topic>TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE</topic><toplevel>online_resources</toplevel><creatorcontrib>MAZAKI MITSUO</creatorcontrib><creatorcontrib>MYAKE MASAHISA</creatorcontrib><creatorcontrib>UEHARA MASAKI</creatorcontrib><creatorcontrib>HIRATE KENJI</creatorcontrib><creatorcontrib>NAKAJIMA YOSHIHARU</creatorcontrib><creatorcontrib>ISOWA YOSHIKAZU</creatorcontrib><creatorcontrib>SATO YOSHIAKI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MAZAKI MITSUO</au><au>MYAKE MASAHISA</au><au>UEHARA MASAKI</au><au>HIRATE KENJI</au><au>NAKAJIMA YOSHIHARU</au><au>ISOWA YOSHIKAZU</au><au>SATO YOSHIAKI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>JP2542241B</title><date>1996-10-09</date><risdate>1996</risdate><abstract>NEW MATERIAL:A peptide (salt) expressed by formula l or a derivative at the functional group thereof. USE:A preventive and treating agent for senile dementia, cerebrovascular dementia, Alzheimer disease, Pick disease, Huntington chorea, Creutzfeldt.Jakob disease, Parkinson disease, cerebellospinal degeneration, etc. PREPARATION:For example, a compound expressed by he formula H-Arg(Mbs)- OBzl (Mbs is p-methoxybenzenesufonyl; OBzl is benzyl ester) is reacted with a compound expressed by the formula Boc-Pro-Osu (Boc is tert-butoxycarbonyl; Osu is N-hyroxysuccinimide ester) in THF to provide a compound expressed by formula II. The alpha-amino-protecting group thereof is then removed and the resultant compound is successively reacted with compounds expressed by the formula Boc-Cys(MBzl)OH (MBzl is p-methoxybenzyl) and Z-Asn-OH (Z is benzyloxycarbonyl) to afford a protected peptide expressed by formula III. The protecting groups are then removed to provide the compound expressed by formula I.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_JP2542241BB2 |
source | esp@cenet |
subjects | CHEMISTRY CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION ORPROCESSING OF GOODS GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE |
title | JP2542241B |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T01%3A44%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MAZAKI%20MITSUO&rft.date=1996-10-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2542241BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |